Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: A randomised controlled trial

British Journal of Nutrition

Volumn 101, Issue 11, 2009, Pages 1679-1687

  Laitinen, Kirsi ^a   Poussa, Tuija ^b   Isolauri, Erika ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b Stat Consulting   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Dietary counselling; Glucose metabolism; Pregnancy; Probiotics

Indexed keywords

BIFIDOBACTERIUM ANIMALIS EXTRACT; GLUCOSE; LACTOBACILLUS RHAMNOSUS EXTRACT; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PERINATAL PERIOD; PREGNANCY; PREGNANT WOMAN; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THIRD TRIMESTER PREGNANCY;

ADULT; BLOOD GLUCOSE; COUNSELING; DIET; ENERGY INTAKE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; POSTPARTUM PERIOD; PREGNANCY; PROBIOTICS; PROSPECTIVE STUDIES; YOUNG ADULT;

BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; LACTOBACILLUS RHAMNOSUS;

EID: 67649443916     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508111461     Document Type: Article

References (43)

1. Ben-Haroush A, Tyogev Y & Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21, 103-113.
2. Östlund I, Hanson U, Björklund A, et al. (2003) Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 26, 2107-2111.
3. Plagemann A, Harder T, Kohlhoff R, et al. (1997) Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia 40, 1094-1100.
4. Clausen T, Burski TK, Oyen N, et al. (2005) Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol 153, 887-894.
5. Godfrey KM & Barker DJP (2000) Fetal nutrition and adult disease. Am J Clin Nutr 71, 344-352.
6. Danaei G, Lawes CMM, Vander Hoorn S, et al. (2006) Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: Comparative risk assessment. Lancet 368, 1651-1659.
7. Ahrén B (2007) Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects. Diabetes Care 30, 644-648.
8. Yamaoka K & Tango T (2005) Efficacy of lifestyle education to prevent type 2 diabetes. Diabetes Care 28, 2780-2786.
9. Bäckhed F, Ding H, Wang T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101, 15718-15723.
10. Turnbaugh PJ, Ley RE, Mahowald MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
11. Bäckhed F, Manchester JK, Semenkovich CF, et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104, 979-984.
12. Goldblum SE, Grann TW, Ding X, et al. (1994) Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J Clin Invest 93, 692-702.
13. Yu B, Hailman E & Wright SD (1997) Lipopolysaccharides binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 99, 315-324.
14. Laitinen K, Hoppu U, Hämäläinen M, et al. (2006) Breast milk fatty acids may link innate and adaptive immune regulation: analysis of soluble CD14, prostaglandin E2 and fatty acids. Pediatr Res 59, 723-727.
15. Shoelson SE, Lee J & Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116, 1793-1801.
16. Ouwehand A, Isolauri E, Kirjavainen PV, et al. (2000) The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol 30, 10-13.
17. Benno Y, He F, Hosoda M, et al. (1996) Effects of Lactobacillus GG yogurt on human intestinal microecology in Japanese subjects. Nutr Today 31, Suppl., 9-11.
18. Kalliomäki M, Kirjavainen P, Eerola E, et al. (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107, 129-134.
19. Kalliomäki M, Salminen S, Arvilommi H, et al. (2001) Probiotics in primary prevention of atopic disease: A randomised, placebo-controlled trial. Lancet 357, 1076-1079.
20. Nordic Working Group on Diet and Nutrition (1996) Nordic Nutrition Recommendations. Scand J Nutr 40, 161-165.
21. Becker W, Lyhne N, Pedersen AN, et al. (2004) Nordic nutrition recommendations 2004 - integrating nutrition and physical activity. Scand J Nutr 48, 178-187.
22. Piirainen T, Isolauri E, Lagström H, et al. (2006) Impact of dietary counseling on nutrient intake during pregnancy: A prospective cohort study. Br J Nutr 96, 1095-1104.
23. Katz A, Nambi SS, Mather K, et al. (2000) Quantitative insulin sensitivy check index: A simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 2402-2410.
24. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
25. Crowther CA, Hiller JE, Moss JR, et al. (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New Engl J Med 352, 2477-2486.
26. Löbner K, Knopff A, Baumgarten A, et al. (2006) Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55, 792-797.
27. Tabuchi M, Ozaki M, Tamura A, et al. (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67, 1421-1424.
28. Matsuzaki T, Nagata Y, Kado S, et al. (1997) Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. APMIS 105, 637-642.
29. Yadav H, Jain S & Sinha PR (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high-fructose fed rats. Nutrition 23, 62-68.
30. Yadav H, Jain S & Sinha PR (2006) Effect of dahi containing Lactococcus lactis on the progression of diabetes induced by a high-fructose diet in rats. Biosci Biotechnol Biochem 70, 1255-1258.
31. Kalliomäki M, Poussa T, Salminen S, et al. (2007) Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119, 1019-1021.
32. Kalliomäki M, Collado MC, Salminen S, et al. (2008) Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87, 534-538.
33. Delzenne NM & Cani PD (2005) A place for dietary fibre in the management of the metabolic syndrome. Micronutrients, neutraceutics and functional foods. Curr Opin Clin Nutr Metab Care 8, 636-640.
34. Membrez M, Blancher F, Jaquet M, et al. (2008) Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22, 2416-2426.
35. Shi H, Kokoeva MV, Inouye K, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116, 3015-3025.
36. Stampfer MJ, Hu FB, Manson JE, et al. (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. New Engl J Med 343, 16-22.
37. Weiss R, Dziura J, Burgert TS, et al. (2004) Obesity and the metabolic syndrome in children and adolescents. New Engl J Med 350, 2362-2374.
38. Ley RE, Turnbaugh PJ, Klein S, et al. (2006) Human gut microbes associated with obesity. Nature 444, 1022-1023.
39. Cani PD, Neyrinck AM, Fava F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383.
40. Creely SJ, McTernan PG, Kusminski CM, et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740-E747.
41. Erridge C, Attina T, Spickett CM, et al. (2007) A high-fat meal induces a low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286-1292.
42. Calder PC (2006) Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75, 197-202.
43. Cani PD, Neyrinck AM, Fava F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383.